Clinical Study on the Disease-Modifying Effects of Rasagiline on Parkinson's Disease Using Machine Learning
Not Applicable
Suspended
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000053427
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 325
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with severely impaired renal function (2) Patients who are pregnant or may be pregnant (3) Patients who are breast-feeding (4) Patients suffering from collagen disease, vasculitis disease, malignant tumor, or severe diabetes mellitus (5) Other patients who are deemed inappropriate as subjects by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms at baseline, 24, 48, 72, and 96 weeks (UPDRS).
- Secondary Outcome Measures
Name Time Method Blood test, brain MRI scan